Verastem (NASDAQ:VSTM) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 45.57 percent increase over losses of $(0.79) per share from the same period last year. The company reported quarterly sales of $18.671 million which missed the analyst consensus estimate of $21.579 million by 13.48 percent.